Grant: Alliance Grants
McMaster University
$30,000.00
Delivery system for Dualase and testing of potential for gene therapy in partnership with Specific Biologics _x000d_
EF 2020-21
Résumé
Specific Biologics Inc., a Toronto based start up, has a novel gene editing technique that they have validated for various research applications and are currently developing for use in the treatment of cystic fibrosis. The technique has greater specificity and fewer off target effects than currently available technologies. Based on the considerable interest in the use of gene therapy in ocular applications, SBI is interested in examining the potential of this protein based technology for its potential in the eye which is currently widely touted as a potential gene therapy target. In partnership with the Sheardown lab from McMaster University, which brings expertise in ophthalmic materials and drug delivery, the project will develop a method of delivering the protein based gene editor to the ocular tissue based on previously established ocular delivery systems and will examine the potential of the system to alter the genome of ocular cells in vitro and in vivo. Specifically the work will look at the specificity of the gene editing and the level of off target effects. Ultimately, this work will allow SBI to assess the ophthalmic potential of their system and to optimize the system for the treatment of a variety conditions and for research applications in the eye.
Programme
Alliance Grants
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
560748-2020
Name nom
Sheardown, Heather
Department département
Chemical Engineering
Organization id
27
Institution établissement
McMaster University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2020
Award amount
30000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
1902
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical materials
Research subject fr
Matériaux biomédicaux
Installment
inst:1 - 1
Partie
1
Nb partie
1
Application title
Delivery system for Dualase and testing of potential for gene therapy in partnership with Specific Biologics _x000d_
Keyword
NSERC
Application summary
Specific Biologics Inc., a Toronto based start up, has a novel gene editing technique that they have validated for various research applications and are currently developing for use in the treatment of cystic fibrosis. The technique has greater specificity and fewer off target effects than currently available technologies. Based on the considerable interest in the use of gene therapy in ocular applications, SBI is interested in examining the potential of this protein based technology for its potential in the eye which is currently widely touted as a potential gene therapy target. In partnership with the Sheardown lab from McMaster University, which brings expertise in ophthalmic materials and drug delivery, the project will develop a method of delivering the protein based gene editor to the ocular tissue based on previously established ocular delivery systems and will examine the potential of the system to alter the genome of ocular cells in vitro and in vivo. Specifically the work will look at the specificity of the gene editing and the level of off target effects. Ultimately, this work will allow SBI to assess the ophthalmic potential of their system and to optimize the system for the treatment of a variety conditions and for research applications in the eye.